Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Amortization of Deferred Charges: 2014-2024

Historic Amortization of Deferred Charges for Syndax Pharmaceuticals (SNDX) over the last 4 years, with Dec 2024 value amounting to $30,000.

  • Syndax Pharmaceuticals' Amortization of Deferred Charges was N/A to $62,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $259,000, marking a year-over-year change of. This contributed to the annual value of $30,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Syndax Pharmaceuticals' Amortization of Deferred Charges stood at $30,000, which was down 92.29% from $389,000 recorded in FY2020.
  • In the past 5 years, Syndax Pharmaceuticals' Amortization of Deferred Charges ranged from a high of $389,000 in FY2020 and a low of $30,000 during FY2024.
  • Its 1-year average for Amortization of Deferred Charges is $30,000, with a median of $30,000 in 2024.